Society Publishers Provide More Than Open Access

Brad FitzpatrickAlively and sometimes acrimonious discussion is raging in scientific and publishing circles over the issue of "open access" to the content of scientific journals, where all papers published in a journal are available, at no charge, to everyone from the day they appear in print. Under this model, the costs associated with publishing are borne solely by the authors, or more likely by their funding sources; readers do not pay for access.The American Society for Biochemistry and Mole

Written byPeter Farnham
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Brad Fitzpatrick

Alively and sometimes acrimonious discussion is raging in scientific and publishing circles over the issue of "open access" to the content of scientific journals, where all papers published in a journal are available, at no charge, to everyone from the day they appear in print. Under this model, the costs associated with publishing are borne solely by the authors, or more likely by their funding sources; readers do not pay for access.

The American Society for Biochemistry and Molecular Biology (ASBMB) is a strong supporter of broad public access to the scientific literature. In 1995, ASBMB's main journal, the Journal of Biological Chemistry (JBC) became the first basic scientific journal to go fully on-line, in partnership with Stanford University's HighWire Press. HighWire Press now hosts on-line editions of 359 journals, including more than 40 of the 100 most-frequently-cited science journals in the world. This translates into about 718,000 ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies